AKIN GUMP STRAUSS HAUER & FELD

Lobbying for CELLDEX THERAPEUTICS, INC. · Biotechnology company developing therapeutics for patients.

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2025 · New Jersey · House · Senate · $60,000.00 income · posted Jul 21, 2025

Lobbying activity 1

Health Issues

Issues related to NIH-funded eosinophilic gastrointestinal disease research.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.